A CROSS-SECTIONAL STUDY TO FIND OUT THE SIGNIFICANT PREVALENCE OF CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETICS IN EASTERN INDIA
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i5.45053Keywords:
Fasting plasma glucose, Urinary ACR, Microalbuminuria, Type 2 diabetes mellitusAbstract
Objectives: Diabetes mellitus (DM) is a metabolic syndrome clinically presenting hyperglycemia with underlying absolute or relative insulin deficiency. Type 2 DM (T2DM) presently comprises about 90% of the diabetic population of the World. Diabetes leads to many complications. One major complication of long-term poorly controlled diabetes is diabetic nephropathy which usually leads to end-stage renal disease (ESRD). There are mainly two crucial markers to assess renal impairment– (1) Glomerular filtration rate (GFR) and (2) Microalbuminuria. The objective of our study is to find out the prevalence of chronic kidney disease (CKD) in T2DM patients.
Methods: We measured glycated hemoglobin (HbA1c), serum creatinine, urinary ACR, and estimated GFR (eGFR) (by Modification of Diet in Renal Disease formula) in selected 105 T2DM patients aged 40–70 years (mean duration of diabetes is 10.01±3.46 years). We analyzed the data by appropriate statistical software and assessed the prevalence of CKD (with Urinary ACR and eGFR) in T2DM patients (with fasting blood glucose, 2-h OGTT, and HbA1c).
Results: This study shows that 30 out of 105 diabetic patients were suffering from CKD, with a prevalence of 28.57%.
Discussion: In our study; out of 105 T2DM patients, 30 (28.57%) patients had some stages of CKD. Nineteen (63.33%) out of these 30 CKD patients had albuminuria (both micro and macroalbuminuria), and 11 (36.67%) out of 30 CKD patients had normoalbuminuria (ACR <30 mg/g).
Conclusion: There is a high prevalence (28.57%) of CKD in T2DM patients, and early detection and treatment of diabetic nephropathy, along with tight glycemic control, helps prevent ESRD.
Downloads
References
Frier M, Fisher BM. Diabetes mellitus. In: Colledge NR, Walker BR,
Ralston SH, editors. Davidson’s Principles and Practice of Medicine.
st ed. United Kingdom: Churchill Livingstone; 2010. p. 793-830.
International Diabetes Federation. Diabetes Blue Circle Symbol.
Brussels, Belgium: International Diabetes Federation; 2006.
World Health Organization. About Diabetes. Geneva: World Health
Organization; 2014.
Phillips DI, Clark PM, Hales CN, Osmond C. Understanding oral
glucose tolerance: Comparison of glucose or insulin measurements
during the oral glucose tolerance test with specific measurements of
insulin resistance and insulin secretion. Diabet Med 1994;11:286-92.
World Health Organization. Diabetes Fact sheet No 312. Geneva:
World Health Organization; 2013. Available from: https://cdn.who.int
[Last accessed on 2014 Mar 25].
Sato F, Tamura Y, Watada H, Kumashiro N, Igarashi Y, Uchino H,
et al. Effects of diet-induced moderate weight reduction on intrahepatic
and intramyocellular triglycerides and glucose metabolism in obese
subjects. J Clin Endocrinol Metab 2007;92:3326-9.
Joshi SR, Parikh RM. India--diabetes capital of the World: Now heading
towards hypertension. J Assoc Physicians India 2007;55:323-4.
Kumar A, Goel MK, Jain RB, Khanna P, Chaudhary V. India towards
diabetes control: Key issues. Australas Med J 2013;6:524-31.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of
diabetes-estimates for the year 2000 and projections for 2030. Diabetes
Care 2004;27:1047-53.
Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in
India. Australas Med J 2014;7:45-8.11. Agarwal SK, Srivastava RK. Chronic kidney disease in India:
Challenges and solutions. Nephron Clin Pract 2009;111:c197-203.
Ritz E, Zeng X. Diabetic nephropathy-Epidemiology in Asia and the
current state of treatment. Indian J Nephrol 2011;21:75-84.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work
Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and
Management of Chronic Kidney Disease. Kidney Int Suppl 2013;3:1-150.
Available from: https://www.franciscokidneycentre.com/stages-ofchronic-
kidney-disease
Thomas L. Clinical Laboratory Diagnostics. 1st ed. Frankfurt: THBooks
Varlagsgesellschaft; 1998. p. 374-7.
Kundu SK, Biswas IB, Roy N. Correlation of HbA1c with urinary ACR,
eGFR and serum creatinine in type 2 diabetes mellitus. J Evolution Med
Dent Sci 2017;6:2353-7.
Waknine Y. Kidney Disease Classification to Include Albuminuria.
French: Medscape Medical News; 2012. Available from: https://
pubmed.ncbi.nlm.nih.gov [Last accessed on 2016 Jul 24].
American Diabetes Association. Standards of medical care for patients
with diabetes mellitus. Diabetes Care 2001;24:33-4.
Tietz NW, editor. Clinical Guide to Laboratory Tests. 3rd ed.
Philadelphia, PA: WB Saunders Company; 1995. p. 186-8.
CLSI. Evaluation of Precision Performance of Quantitative
Measurement Methods; Approved Guideline. 2nd ed. CLSI Document
EP5-A2. United States: CLSI; 2008.
Bakker AJ, Mucke M. Gammopathy interference in clinical chemistry
assays: Mechanisms, detection, and prevention. Clin Chim Lab Med
;45:1240-3.
Young DS. Effects of Drugs on Clinical Laboratory Tests. 5th ed.
Vol. 1-2. Washington, DC: The American Association for Clinical
Chemistry Press; 2000.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more
accurate method to estimate glomerular filtration rate from serum
creatinine: A new prediction equation. Modification of Diet in Renal
Disease Study Group. Ann Intern Med 1999;130:461-70.
Ekinci EI, Jerums G, Skene A, Crammer P, Power D, Cheong KY. Renal
structure in normoalbuminuric and albuminuric patients with type 2
diabetes and impaired renal function. Diabetes Care 2013;36:3620-6.
Bloomgarden ZT. Diabetic nephropathy. Diabetes Care 2005;28:745-51.
Rodriguez-Poncelas A, Garre-Olmo J, Franch-Nadal J, Diez-Espino J,
Mundet-Tuduri X, Barrot-De la Puente J, et al. Prevalence of chronic
kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2
study. BMC Nephrol 2013;14:46.
Lou Arnal LM, Campos Gutiérrez B, CuberesIzquierdo M,
GraciaGarcía O, TurónAlcaine JM, BielsaGarcía S. Prevalence of
chronic kidney disease in patients with type 2 diabetes mellitus treated
in primary care. Nefrologia 2010;30:552-6.28. Vinagre I, Mata-Cases M, Hermosilla E, Morros R, Fina F, Rosell M,
et al. Control of glycemia and cardiovascular risk factors in patients
with type 2 diabetes in primary care in Catalonia (Spain). Diabetes Care
;35:774-9.
Coll-de-Tuero G, Mata-Cases M, Rodriguez-Poncelas A,
Pepió JM, Roura P, Benito B, et al. Chronic kidney disease in
type 2 diabetic patients: Prevalence and associated variables in
a random sample of 2642 patients of a Mediterranean area. BMC
Nephrol 2012;13:87.
van der Meer V, Wielders HP, Grootendorst DC, de Kanter JS,
Sijpkens YW, Assendelft WJ. Chronic kidney disease in patients with
diabetes mellitus type 2 or hypertension in general practice. Br J Gen
Pract 2010;60:884-90.
New JP, Middleton RJ, Klebe B, Farmer CK, de Lusignan S,
Stevens PE. Assessing the prevalence, monitoring, and management of
chronic kidney disease in patients with diabetes compared with those
without diabetes in general practice. Diabet Med 2007;24:364-9.
Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, et al.
Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
Clinical significance of nonalbuminuric renal impairment in type 2
diabetes. J Hypertens 2011;29:1802-9.
Plantinga LC, Crews DC, Coresh J, Miller ER, Saran R, Yee J.
Prevalence of chronic kidney disease in US adults with undiagnosed
diabetes or prediabetes. Clin J Am Soc Nephrol 2010;5:673-82.
Thomas MC, Weekes AJ, Broadley OJ, Cooper ME, Mathew TH. The
burden of chronic kidney disease in Australian patients with type 2
diabetes (the NEPHRON study). Med J Aust 2006;185:140-4.
Ohta M, Babazono T, Uchigata Y, Iwamoto Y. Comparison of the
prevalence of chronic kidney disease in Japanese patients with Type 1
and Type 2 diabetes. Diabet Med 2010;27:1017-23.
Krairittichai U, Potisat S, Jongsareejit A, Sattaputh C. Prevalence and
risk factors of diabetic nephropathy among Thai patients with type 2
diabetes mellitus. J Med Assoc Thai 2011;94:S1-5.
Jia W, Gao X, Pang C, Hou X, Bao Y, Liu W. Prevalence and risk factors
of albuminuria and chronic kidney disease in A Chinese population
with type 2 diabetes and impaired glucose regulation: Shanghai diabetic
complications study (SHDCS). Nephrol Dial Transp 2009;24:3724-31.
1093/ndt/gfp349.
Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shantirani CS,
Deepa R, et al. Prevalence and risk factors of diabetic nephropathy in an
urban South Indian population: The Chennai Urban rural epidemiology
study (CURES 45). Diabetes Care 2007;30:2019-24.
Agarwal SK, Srivastava RK. Chronic kidney disease in India:
Challenges and solutions. Nephron Clin Pract 2009;111:c197-203.
Rajapurkar M, Dabhi M. Burden of disease-prevalence and incidence
of renal disease in India. Clin Nephropathy 2010;12:9-11.
Published
How to Cite
Issue
Section
Copyright (c) 2022 SANDIP KUMAR KUNDU, SIBAPRAKASH MUKHERJEE, SHUBHRANGSU SAMANTA
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
